| Completed | A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How S Growth Hormone Deficiency | Phase 3 | 2021-11-16 |
| Completed | Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency Growth Hormone Deficiency With Pituitary Anomalies | Phase 3 | 2015-12-03 |
| Completed | Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Endometrial Cancer | Phase 3 | 2013-04-01 |
| Terminated | Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer Breast Cancer | Phase 2 | 2012-12-01 |
| Completed | A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies Cancer | Phase 1 | 2012-01-24 |
| Terminated | A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy Urothelial Carcinoma | Phase 1 / Phase 2 | 2010-11-01 |
| Completed | Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Colorectal Cancer | Phase 3 | 2010-04-01 |
| Terminated | Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients Multiple Myeloma | Phase 3 | 2009-12-01 |
| Completed | Study of Perifosine + Capecitabine for Colon Cancer Patients Colon Cancer | Phase 1 | 2009-10-01 |
| Completed | Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Mul Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer | N/A | 2008-05-01 |
| Completed | Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) Benign Prostatic Hypertrophy | Phase 3 | 2008-03-01 |
| Completed | Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) Benign Prostatic Hypertrophy | Phase 3 | 2008-03-01 |
| Completed | Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors Ovarian Cancer, Endometrial Cancer | Phase 2 | 2007-12-01 |
| Completed | Ph II Study of Perifosine for Patients With Carcinoma of the Kidney Kidney Cancer | Phase 2 | 2007-07-01 |
| Completed | Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test. Diagnosis of Adult Growth Hormone Deficiency (AGDH) | Phase 3 | 2007-06-01 |
| Terminated | Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) Benign Prostatic Hypertrophy | Phase 3 | 2007-03-01 |
| Completed | A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Canc Renal Cell Carcinoma | Phase 2 | 2007-03-01 |
| Completed | Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma Multiple Myeloma | Phase 1 | 2006-12-01 |
| Completed | A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Chondrosarcomas, Alveolar Soft Part Sarcomas, Extra Skeletal Myxoid Chondrosarcomas | Phase 2 | 2006-11-01 |
| Completed | Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia Leukemia | Phase 2 | 2006-10-01 |
| Completed | A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia Waldenström's Macroglobulinemia | Phase 2 | 2006-10-01 |
| Completed | Perifosine + Sunitinib Malate for Patients With Advanced Cancers Renal Cancer, GIST | Phase 1 | 2006-10-01 |
| Completed | Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers Renal Cancer, Tumors | Phase 1 | 2006-10-01 |
| Completed | Ph II Study of Perifosine Plus Gleevec for Patients With GIST Gastrointestinal Stromal Tumors | Phase 2 | 2006-08-01 |
| Completed | Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1 / Phase 2 | 2006-08-01 |
| Completed | Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma Multiple Myeloma | Phase 2 | 2005-12-01 |
| Completed | Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients Colon Cancer | Phase 2 | 2005-08-01 |
| Completed | Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas Tumors, Lymphomas | Phase 2 | 2005-01-01 |
| Completed | Phase I Trial of Docetaxel With Perifosine Neoplasms | Phase 1 | 2004-11-01 |
| Completed | Phase I Trial of Paclitaxel With Perifosine Neoplasms | Phase 1 | 2004-11-01 |
| Completed | A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2004-09-01 |
| Completed | Phase I Perifosine and Gemcitabine Study Neoplasms | Phase 1 | 2004-08-01 |
| Completed | AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2001-04-01 |
| Completed | AE-941 in Treating Patients With Metastatic Kidney Cancer Kidney Cancer | Phase 3 | 2000-10-01 |